2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
69
Breast Neoplasms
52
Carcinoma, Non-Small-Cell Lung
28
Neoplasms
27
Myelodysplastic Syndromes
27
Advanced Solid Tumors
27
Advanced Solid Tumor
26
Prostatic Neoplasms
24
Stomach Neoplasms
19
Recurrence
18
Multiple Myeloma
18
Carcinoma, Hepatocellular
18
Neoplasm Metastasis
17
Ovarian Neoplasms
15
Lung Neoplasms
15
Pancreatic Neoplasms
14
Uterine Cervical Neoplasms
13
Solid Tumor
13
Sarcoma
13
Melanoma
13
Leukemia, Myelomonocytic, Chronic
13
Colorectal Neoplasms
11
Triple Negative Breast Neoplasms
10
Small Cell Lung Carcinoma
10
Lymphoma, Large B-Cell, Diffuse
10
Squamous Cell Carcinoma of Head and Neck
8
Myeloproliferative Disorders
8
Lymphoma, Non-Hodgkin
8
Esophageal Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Interventions
Irinotecan
6
Gemcitabine
5
130-nm albumin-bound paclitaxel
5
Oxaliplatin
4
Fluorouracil
4
Capecitabine
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
napabucasin
3
Ocoxin
3
Leucovorin
3
pembrolizumab
2
Sorafenib
2
Paclitaxel
2
Nivolumab
2
Drug Therapy
2
Cyclophosphamide
2
Colonoscopy
2
Cetuximab
2
Bupivacaine
2
Aspirin
2
Ascorbic Acid
2
trifluridine tipiracil drug combination
1
trametinib
1
pralsetinib
1
penpulimab
1
ozanimod
1
lutetium Lu 177 dotatate
1
linifanib
1
hetrombopag
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Digestive System Diseases
×
Injections
×
Clear all
NCT06153394
2024-04-23
PRIORITY
Western University, Canada
Phase 3
Not yet recruiting
50 enrolled